Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
1,622,482 shares sold by Asher today.
i think he's demonstrated over the last several years that he is neither unless the only prerequisite is looking out for himself.
- Massive dilution of shares
- Laying promises of a bridge to nowhere
- Undelivered everything.
- Mischaracterizing the involvement of Abbott and Inverness
Maybe Moro can produce a certificate from Uruguay that he is a Medical Doctor. On the other side, I would like to see his credentials of competent scientist and businessman?
Over 4 million shares sold by Asher today.
Just like back in 2009 when Moro exercised a bunch of options so he could vote the proxy and now he returns the 80 million shares after voting the latest proxy.
This also gives Moro another 80 million shares he can issue to lenders / employees and still stay under the 450 million max authorized shares.
It is now very obvious that FINRA has refused to authorize the reverse split Moro requested.
Almost unbelievable but indeed the work of a true scammer.
1. Shares were returned to Biocurex, Inc. and debt owed to Pacific BioScience Research Centre, which is controlled by Dr. Ricardo Moro, Chief Executive Officer of Biocurex, Inc., was re-assumed.
link below.
http://www.sec.gov/Archives/edgar/data/1092562/000100487812000309/xslF345X03/primary_doc.xml
Vamm, I think Moro has played this scam a lot longer than most scammers.
He has been able to hide behind a medical degree giving the product an ability to be sold to the naive. I would actually like to see what his medical degree actually consists of. Has anyone ever checked to see if it is a valid degree?
Well Gold, it looks like the fat lady has sung.
As it turns out you were correct all along, despite what Glass Half Full thinks.
Shareholders need to question why Moro would immediately issue 5.7 million shares from the incentive fund right after 18 million shares had been sold to pay employees.
As soon as the S8 registration was filed, the selling began and the seller was consistently hitting the bid.
It has also been over 45 days since the shareholder vote approving the reverse split. Something is up with FINRA not approving the split.
This has become an impossible situation for Moro. He is running out of shares to issue, laid off emmployees and Smithline will foreclose.
Now you probably realize why Moro has always rented his residence in Canada. IMO, I think he could easily hot foot it to Uruguay and take the SR&ED money with him.
Asher sells another million shares today.
Moro registerers another 50 million shares for the employee incentive fund so he can pay for services and give stock to employees for pay.
Moro has now tapped into the shares that were reserved for the warrants. That probably wont be a problem because those warrants will never be exercised.
IMO, Moro made a huge mistake when he held the last shareholder meeting. He should have voted to raise the authorized shares to 5 billion.
About a million shares today were sales by Asher.
The next loan from Asher is convertible on October 15 for $32,500.
The Asher loans convert at 58% of the current 5 day average. Based on the low for today, that amount will convert into over 37 million shares. Without the reverse split, I don't think Moro will have enough authorized shares to cover the loan.
New all time low set today of $.0015. The bottom for a penny stock is .0001.
Moro got the reverse split vote approved at the end of July. He immediately needs the reverse split effected because he is running out of shares and will soon be at the 450 million max authorized level.
You can rightly assume that Moro has applied to FINRA to approve a reverse split. Normally, they will answer a request within about two weeks so obviously, they are taking more time to look into BioCurex. I think he will eventually get a reverese split but it wont be 1 for 150 but something much less. FINRA will not want to eliminate any shareholders.
3.63 million dumped today with a new all time low of .0017.
New all time low this morning of .0018. Asher continues to dump shares via their death spiral terms.
Moro hasn't gotten any more financing. He has laid off all but three of his employees at Pacific BioSciences and there is no indication in the filings that he has paid any of the required payments to Smithline.
With the share price declining, Moro's ability to pay for services vis shares becomes extremely limited. There are only 450 million authorized and he has over 400 million already obligated. He needs the reverse split ASAP.
Of the 8.8 million traded today, 2.5 million was sold by Asher.
Yes, you did, Gold, and thank you!! But even with that, I have enough in tax-loss carry-forwards to last about thirty years at $3000 a year. I bought BOCX for up to a dollar! I have thought for a long time that Moro misrepresented the successes of his trials, but too late. Buyer beware!
What is Moro's next ploy?
He has the stock reverse split approved by a shareholder vote so what is next. Next is approval by FINRA which he may or may not get.
The share price is the lifeblood of Biocurex. He needs the share price up to pay his empoyees stock, pay for consultants and to pay off Asher.
One thing I am reminded of is the fake PR. It is certainly something Moro would do so how does it work?
First of all, it has to be foreign so it cannot be verified and almost always involves an "Anonymous" company or group. This could include an investment in the company or even another license for RECAF.
What ever Moro comes up with in the next month or so will be fake and you will not be able to verify it. That is the way the scam works and Moro is king of all the scams.
Half, that modification would give Smithline the right to go after the money. Good luck fighting Smithline Half. I hope Smithline gets all the money that has been stolen from shareholders.
Which do you think has priorty Moro? An agreement made earlier or one made later? Half, you could always give the money back.
Gold that was part of a loan modification in 2010 not the contract between Biocurex and Pacific Biosciences.
Where is the agreement between Pacific and Biocurex?
Half, Moro has been stealing the money from BioCurex.
This is what the contract states:
"115% of the fully absorbed cost to Pacific BioSciences"
What do you think a jury would find "fully absorbed cost" to mean?"
For what it looks like, any company doing R&D in Canada receives the refund. Moro is incompetent but not to such extent that will not claim the money. So it is not a question of if Pacific is receiving the refund. If Moro is not passing the refund to Biocurex, he is stealing the money.
Gold, When you are standing in front of the judge and jury...All they want to see are the legal contracts.
You are always posting supposed legal issues with regard to Biocurex...What does the contract state between Pacific Biosciences and Biocurex with regard to rebates? Who do they belong to? Its as simple as paper or plastic?
All of these people are losing their houses...They signed a contract stating they would pay x dollars for the use of the banks money. When they couldn't pay up they lost the house.
Bad Banker? or Bad Borrower? What did the contract state?
Half, I used to think you were just a naive shareholder but you stance of supporting Moro in his theft of up to $1.5 million from BioCurex now places you in a different light.
There would be ZERO true shareholders supporting Moro at this point.
Hungry,
Business is ruled by legal contracts. If Biocurex agreed to pay Pacific an amount of money, then they agreed to pay them a specific amount of money.
If Pacific Bioscience gets a free lunch after that agreement was made, then the free lunch belongs to Pacific Bioscience.
What does the agreement between Biocurex and Pacific state?
Until that is known and until someone can prove that a rebate is even being given, all this BS from GS is smoke and mirrors.
Isn't the tax refund provided by the Canadian Revenue Agency? If Moro is getting refunds, he needs to return the money to Biocurex not the Canadian Agency.
LT, even though Asher has death spiral terms, they are not killing the stock and have only been selling when there is some sort of demand for the stock. Yesterdays total sales was just over $6,000.
I suspect that Moro has been spinning some tall tales in private with some investors.
If Asher is the seller, who is the buyer?
Half, it is unbelievable that you are attempting to defend Moro's theft of up to $1.5 million from BioCurex.
The following are all the trades for today. All of the bold face trades are from Asher.
$0.0031
38,400
OTO
14:39:40
$0.0030
92,600
OTO
14:25:38
$0.0030
500,000
OTO
13:15:30
$0.0030
330,000
OTO
13:09:58
$0.0030
300,000
OTO
12:45:47
$0.0030
500,000
OTO
12:41:08
$0.0030
58,000
OTO
12:35:52
$0.0030
117,000
OTO
12:21:47
$0.0030
25,000
OTO
12:21:35
$0.0027
300,000
OTO
12:21:17
$0.0022
2,400
OTO
09:31:58
Gold, In response to your question, Did you or Do you give your tax refund back to the company who provided it to you?
The volume today came from Asher.
20120821|BOCX|2063400|0|2263400|O
2,063,400 shares sold in unresolved trades or 91% of the shares came from Asher.
Why don't you tell us? You are Moro talk a lot, don't you.
By the way, if Pacific is receiving tax refunds and not passing them to Biocurex, is Moro a thief?
Maybe the fake rumor has been started.
Hmm, What's up with the volume today? 2,132,000 shares...
What is left for Moro to pump?
IMO, there is nothing left but looking back at some of the other penny stocks, there is always the fake buyout with the undisclosed offer.
That is a classic penny stock maneuver.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=49603685
I_Invest, it is sad that more people did not realize what a scam Moro was running a lot earlier. Moro would have been "double dipping" and pocketing the SR&ED money for years.
Moro continued to tout a license with Abbott for years that was clearly bought by letting Abbott not pay a royalty that was due. This was just typical of the manipulation Moro has done to confuse and extract money from investors.
The one thing that I am most proud about is helping Great Grandma get the information she needed to decide to sell. She got out in the high 20's.
I have forever been accused of being a "paid basher" or trying to "steal" someones shares but none of that could be further from the truth. I merely wanted an honest assessment of this stock to be presented and listening to Moro was about the worst thing someone could do when searching for the truth.
I_Invest, Moro has been cutting expenses and employees have apparently be laid off since the filings only indicate 3 employees being paid with shares.
As for the ISOBM, the last articles Moro submitted for publication were very old studies using the Radio-immuno assay. I don't think he has done anything new in quite a while and he has openly stated the the human side has been put on hold while they concentrate on Vet tests. The Vet side has not been successful so what does Moro do now?
Any attendance at the ISOBM will be on his own dime because BioCurex has no money to pay his expenses.
pumping air into a corpse....
I have taken my loses and accpeted the fact that this pipe dream delivered less than a lucid dream.
why would lab people be out selling?
this goose is cooked....
wonder when we're gonna see the fluff for the upcoming ISOBM...
"Some people — we don't know how many — would actually come out negative, they would lose (quality years),"
That is a bogus study because they totally admit they have no idea how many would be hurt or to what degree.
It seems the PSA test is going to be debated a long time.
PSA Test Adds 3 Weeks to Man's Life: Study
Thursday, August 16, 2012 7:58 AM
The possible benefits and harms of prostate cancer screening have been hotly debated in recent years, but for the first time a new study tries to put a number on the balance of pluses and minuses for the average man.
Using data from past cancer studies and a mathematical model, researchers from the Netherlands calculated that on average, annual screening using prostate-specific antigen (PSA) testing would add three healthy weeks to a man's life.
That doesn't mean everyone should run out and get a PSA test, however.
Whether screening has a net benefit or harm for a particular man depends on how he feels about the possibility of suffering screening- and treatment-related side effects — and how much erectile dysfunction or incontinence, for example, would influence his quality of life, researchers said.
"We're even more sure than ever that it's important for doctors and their patients to talk about the prostate cancer screening decision and its potential downstream consequences," said Dr. Harold Sox, a professor of medicine at the Dartmouth Institute in Hanover, New Hampshire, who wrote a commentary published with the new study.
"Now we have some real scientific evidence that a person's choice probably should reflect what the net benefit is for them."
For the new study, Dr. Harry de Koning of the Erasmus Medical Center in Rotterdam and his colleagues built a model based on data from a European trial in which over 160,000 men were randomly assigned to undergo regular PSA testing or forgo screening.
They considered the benefits of catching some cancers early — including a lower chance of dying from prostate cancer — as well as the harms of so-called overdiagnosis. Cancers caught during screening are considered overdiagnosis if they never would have produced symptoms or threatened a man's lifespan. In those cases, treatment can cause side effects but won't do men any good.
The researchers determined that for every 1,000 men getting annual screening in their late fifties and sixties, there would be nine fewer prostate cancer deaths, 247 extra negative biopsies performed and 41 additional men getting prostate surgery or radiation. Forty-five cancers would be overdiagnosed due to screening.
Based on the effects of screening and treatment on each man's quality and length of life, those 1,000 men would ultimately gain 73 extra years of life, or 56 "quality" healthy years.
But the change in quality years due to screening could range anywhere from a loss of 21 healthy years over the 1,000 men to a gain of 97 years, de Koning's team reported Wednesday in the New England Journal of Medicine.
"Some people — we don't know how many — would actually come out negative, they would lose (quality years)," Sox said. "And other people would gain. Therefore it's hard to make one rule that would apply to everybody."
QUESTIONS, CONFLICTING DATA REMAIN
De Koning said that at the very least, his study argues against the notion that PSA screening is typically a bad idea for healthy men.
He and some of his colleagues have received consulting fees from pharmaceutical and medical device companies, including a company that designs PSA tests.
In May, the U.S. Preventive Services Task Force, a government-backed panel, recommended against PSA screening for prostate cancer in men without symptoms.
"This statement that has been around for the last couple of years now saying the benefits don't outweigh the harms - that I think is not true, it's too easy," de Koning told Reuters Health.
Still, he said, "at the individual level, you do not know whether you as the individual will get the benefits or the harms."
While the European study showed a 29 percent reduction in the chance of dying from prostate cancer in men who were screened, another large trial from the U.S. failed to show any survival benefit.
Sox said it's possible some of the figures used in the new model don't accurately reflect men's feelings about having a radical prostatectomy and ending up with erectile dysfunction and urinary incontinence, or getting radiation and developing chronic diarrhea, for example. Still, he said the study is a step in the right direction, toward appropriately weighing the long-term harms and benefits of screening.
"It's the first research article about screening that tried to incorporate the feelings of patients toward what they might experience if they underwent screening," Sox said.
"The problem (in other studies) is that the benefits are measured in one way and harms are measured another way. You end up making that judgment about whether the benefits exceed the harms, or vice versa, purely subjectively," he added.
One question that still remains is whether screening all men of a certain age is cost-effective for society, de Koning pointed out.
According to the American Cancer Society, one in six men will be diagnosed with prostate cancer at some point in their lives and one in 36 men will die of the disease.
The researchers agreed that individual men should think about how they weigh both the possible benefits and harms of getting screened for prostate cancer and discuss the decision with their doctor.
"One man might say, ‘I won't take my chances,'" de Koning said — while another will accept the risk of overdiagnosis and related side effects and still choose to get screened.
© 2012 Reuters. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters.
Rocketman, down to 3 employees and not much happening. Has the light come on yet?
For your information everyone at Biocurex is out working hard to sell product. I know because I called Monday morning and no one was in. I called back Monday afternoon and everyone had left. I called back on Tuesday morning and no one was in. Good job Dr Moro we know it's a tough market out there and you are doing your best!
"In April 2009, the Company issued 418,060 shares of common stock at a fair value of $33,863 to eight employees ."
"In June 2012, the Company issued 6,556,800 shares of common stock to three employees."
This definitely indicates that Moro has laid off some employees and the consultant is no longer listed. It would appear that Moro is no longer doing much R&D at all.
10Q filed and Revenue drops 40% to only $8,826
http://www.sec.gov/Archives/edgar/data/1092562/000155479512000013/bocx0810form10q.htm
Third Death Spiral loan made by Asher. Asher begins to convert notes today with the sale of 343,800 shares.
Followers
|
80
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
30387
|
Created
|
04/11/04
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |